Project Grant HT94252410978
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$571K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
This $682,472 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research by the Sanford Burnham Prebys Medical Discovery Institute (SBP) to selectively target mutant SHP2 oncoproteins in rare leukemias. The award will fund SBP's efforts to advance understanding of the fundamental mechanisms of disease and develop innovative therapies, with a focus on areas such as cancer, aging, neurodegenerative...
The University of California, San Diego (UCSD) was awarded a $551,207.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to research a new therapeutic target to prevent pancreatic cancer metastasis. The 3-year grant period runs from July 1, 2023 to June 30, 2026. The project aims to investigate medical solutions for the battlefield by transforming health care through innovative and impactful research in areas like cancer...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $728,450.00 to Cold Spring Harbor Laboratory (CSHL) to conduct research on "Communication Between Cancer-Associated Fibroblasts and Neurons Promotes Pancreatic Cancer Progression." The research aims to advance scientific understanding of how interactions between cancer cells and the surrounding non-cancerous cells, such as fibroblasts and neurons,...
This federal Project Grant award of $610,059.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Johns Hopkins University to investigate "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The award has a performance period from July 1, 2025 to June 30, 2028 and aims to transform healthcare for military service members, veterans, and the general public through innovative biomedical...
The federal Project Grant award of $974,355.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Sanford Burnham Prebys Medical Discovery Institute. The award supports a research project entitled "WHITE ADIPOSE TISSUE SURROUNDING LYMPH NODES MODULATES ANTIMELANOMA IMMUNITY" with a performance period from July 1, 2024 to June 30, 2027. The funding will enable the Sanford Burnham Prebys Medical Discovery...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $388,194 to The Johns Hopkins University to conduct research on "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions for critical health challenges. The 3-year project, running from...
The Sanford Burnham Prebys Medical Discovery Institute (SBPMDI) was awarded a $1.46 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year award will fund research to therapeutically target a lipid kinase regulator of mutant p53 in breast cancer. Through February 2021 to January 2024, SBPMDI researchers will investigate medical solutions for breast cancer by exploring the role of lipid signaling pathways...
This federal Project Grant award of $195,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the Sanford Burnham Prebys Medical Discovery Institute (SBP) to investigate the function and therapeutic potential of R loops in glioblastoma. The research project will be conducted over a 2-year period from August 1, 2025 to July 31, 2027. SBP, a non-profit biomedical research organization, has extensive experience conducting...
This $729,690 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports metabolic intervention research to halt pancreatic cancer at Cedars-Sinai Medical Center in West Hollywood, California. The project will run from November 1, 2024 to October 31, 2027, investigating innovative approaches to disease prevention, diagnosis, treatment, and management of pancreatic cancer. As a prominent research institution,...
This federal Project Grant award of $144,018.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the Beckman Research Institute of the City of Hope in conducting a telehealth intervention to impact quality of life and pancreatic cancer survivorship. The award period runs from August 1, 2024 to July 31, 2027. The Project Grant aims to develop and evaluate a telehealth-based intervention to improve outcomes for pancreatic...